Reaction Details Report a problem with these data
Target
SUMO-conjugating enzyme UBC9
Ligand
BDBM33055
Substrate
n/a
Meas. Tech.
AlphaScreen confirmatory assay for validation of inhibitors of SUMOylation
IC50
1540±n/a nM
Citation
 PubChem, PC AlphaScreen confirmatory assay for validation of inhibitors of SUMOylation PubChem Bioassay (2010)[AID] 
Target
Name:
SUMO-conjugating enzyme UBC9
Synonyms:
UBC9 | UBC9_HUMAN | UBCE9 | UBE2I | ubiquitin-conjugating enzyme E2I
Type:
Enzyme Catalytic Domain
Mol. Mass.:
18011.66
Organism:
Homo sapiens (Human)
Description:
gi_4507785
Residue:
158
Sequence:
MSGIALSRLAQERKAWRKDHPFGFVAVPTKNPDGTMNLMNWECAIPGKKGTPWEGGLFKLRMLFKDDYPSSPPKCKFEPPLFHPNVYPSGTVCLSILEEDKDWRPAITIKQILLGIQELLNEPNIQDPAQAEAYTIYCQNRVEYEKRVRAQAKKFAPS
  
Inhibitor
Name:
BDBM33055
Synonyms:
2,3-bis(2-furanyl)-N-phenyl-6-quinoxalinecarboxamide | 2,3-bis(2-furyl)-N-phenyl-quinoxaline-6-carboxamide | 2,3-bis(furan-2-yl)-N-phenyl-quinoxaline-6-carboxamide | 2,3-bis(furan-2-yl)-N-phenylquinoxaline-6-carboxamide | 2,3-di-2-furyl-N-phenyl-6-quinoxalinecarboxamide | MLS000050204 | SMR000077343 | cid_2213073
Type:
Small organic molecule
Emp. Form.:
C23H15N3O3
Mol. Mass.:
381.3835
SMILES:
O=C(Nc1ccccc1)c1ccc2nc(-c3ccco3)c(nc2c1)-c1ccco1
Structure:
Search PDB for entries with ligand similarity: